DadFinStart your free week
DadFin › Stocks › Healthcare › MEDS

DataMEDS AI, Inc. (MEDS) stock score

Healthcare · Medical Distribution · United States

$2.96 ▼ -12.94% today

23.2
Dad Score, out of 100
weak

DataMEDS AI, Inc. (MEDS) is a Medical Distribution company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 23.2 out of 100 on the Dad Score, a weak reading that places the business ahead of 23% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #708 of 974. Its strongest axes are price action, risk and liquidity; its weakest are valuation and quality.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Weak
Quality
Weak
Growth
Average
Price action
Above average
Risk
Above average
Conviction
Below average
Liquidity
Above average
Macro
Weak

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)0.0×
P/E (forward)0.0×
Dividend yield0.00%
Return on capital—
Operating margin-412.7%
Revenue growth (YoY)+28.7%
FCF yield-33.2%
Net debt / EBITDA3.00×
Piotroski F-Score2 / 9
52-week change-89.7%
Market cap$12M
Next earningsNov 18, 2026

What subscribers see on MEDS

Start your free weekSubscriber? Open the full research →

Medical Distribution peers

StockCompanyDad ScoreBandMarket cap
MCKMcKesson Corporation92.1strong$105.2B
CORCencora, Inc.70.0good$59.0B
CAHCardinal Health, Inc.97.0strong$52.9B
HSICHenry Schein, Inc.82.6good$9.7B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.